{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:14:07Z","timestamp":1794899647609,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01408-y","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:31:59Z","timestamp":1776148319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of AI in oncology: present applications and future horizons"],"prefix":"10.1038","volume":"10","author":[{"given":"Aidan","family":"Weitzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364\u20131374 (2020).","DOI":"10.1136\/bmj.m3164"},{"key":"1408_CR2","doi-asserted-by":"crossref","unstructured":"Cruz Rivera, S. et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Nat. Med. 26, 1351\u20131363 (2020).","DOI":"10.1136\/bmj.m3210"},{"key":"1408_CR3","unstructured":"Saltman, A. FDA\u2019s Regulation of AI\/ML SaMD. NAMSA. https:\/\/namsa.com\/resources\/blog\/fdas-regulation-of-ai-ml-samd\/ (2024)."},{"key":"1408_CR4","doi-asserted-by":"crossref","unstructured":"Chow, R. et al. Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis. J. Natl. Cancer Inst. 115, 365\u2013374 (2023).","DOI":"10.1093\/jnci\/djad013"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/S2589-7500(24)00047-5","volume":"6","author":"R Han","year":"2024","unstructured":"Han, R. et al. Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review. Lancet Digit. Health 6, e367\u2013e373 (2024).","journal-title":"Lancet Digit. Health"},{"key":"1408_CR6","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/jamia\/ocae243","volume":"31","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review. J. Am. Med. Inform. Assoc. 31, 2749\u20132759 (2024).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"1408_CR7","doi-asserted-by":"crossref","unstructured":"Wang, K. et al. Evaluation of an artificial intelligence-based clinical trial matching system in Chinese patients with hepatocellular carcinoma: a retrospective study. BMC Cancer 24, 246 (2024).","DOI":"10.1186\/s12885-024-11959-7"},{"key":"1408_CR8","doi-asserted-by":"publisher","first-page":"103066","DOI":"10.1016\/j.artmed.2025.103066","volume":"161","author":"M Saady","year":"2025","unstructured":"Saady, M., Eissa, M., Yacoub, A. S., Hamed, A. B. & Azzazy, H. M. E. S. Implementation of artificial intelligence approaches in oncology clinical trials: a systematic review. Artif. Intell. Med 161, 103066 (2025).","journal-title":"Artif. Intell. Med"},{"key":"1408_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41746-025-01886-7","volume":"8","author":"D Teodoro","year":"2025","unstructured":"Teodoro, D., Naderi, N., Yazdani, A., Zhang, B. & Bornet, A. A scoping review of artificial intelligence applications in clinical trial risk assessment. npj Digit. Med. 8, 486 (2025).","journal-title":"npj Digit. Med."},{"key":"1408_CR10","doi-asserted-by":"crossref","unstructured":"Jin, Q. et al. Matching patients to clinical trials with large language models. Nat. Commun. 15, 9074 (2024).","DOI":"10.1038\/s41467-024-53081-z"},{"key":"1408_CR11","unstructured":"ARTIFICIAL INTELLIGENCE Connecting Patients to Clinical Trials with Artificial Intelligence\u2014American Urological Association. https:\/\/auanews.net\/issues\/articles\/2024\/march-2024\/artificial-intelligence-connecting-patients-to-clinical-trials-with-artificial-intelligence."},{"key":"1408_CR12","doi-asserted-by":"crossref","unstructured":"Park, J. et al. Criteria2Query 3.0: Leveraging generative large language models for clinical trial eligibility query generation. J. Biomed. Inform. 154, 104649 (2024).","DOI":"10.1016\/j.jbi.2024.104649"},{"key":"1408_CR13","doi-asserted-by":"crossref","unstructured":"Datta, S. et al. AutoCriteria: a generalizable clinical trial eligibility criteria extraction system powered by large language models. J. Am. Med. Inform. Assoc. 31, 375\u2013385 (2024).","DOI":"10.1093\/jamia\/ocad218"},{"key":"1408_CR14","doi-asserted-by":"crossref","unstructured":"Klein, H. et al. MatchMiner: an open-source platform for cancer precision medicine. npj Precis. Oncol. 6, 69 (2022).","DOI":"10.1038\/s41698-022-00312-5"},{"key":"1408_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1001\/jama.2025.10264","volume":"334","author":"R Perlis","year":"2025","unstructured":"Perlis, R. & Watts, J. How AI could increase clinical trial enrollment in adults with cancer. JAMA 334, 496 (2025).","journal-title":"JAMA"},{"key":"1408_CR16","doi-asserted-by":"crossref","unstructured":"Mazor, T. et al. Clinical trial notifications triggered by artificial intelligence-detected cancer progression. JAMA Netw. Open 8, e252013 (2025).","DOI":"10.1001\/jamanetworkopen.2025.2013"},{"key":"1408_CR17","doi-asserted-by":"crossref","unstructured":"Gupta, S. et al. PRISM: Patient Records Interpretation for Semantic Clinical Trial Matching system using large language models. npj Digit. Med. 7, 305 (2024).","DOI":"10.1038\/s41746-024-01274-7"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41746-025-01674-3","volume":"8","author":"JT Rosenthal","year":"2025","unstructured":"Rosenthal, J. T., Beecy, A. & Sabuncu, M. R. Rethinking clinical trials for medical AI with dynamic deployments of adaptive systems. npj Digit. Med. 8, 252 (2025).","journal-title":"npj Digit. Med."},{"key":"1408_CR19","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1038\/s41591-023-02540-z","volume":"29","author":"A Youssef","year":"2023","unstructured":"Youssef, A. et al. External validation of AI models in health should be replaced with recurring local validation. Nat. Med. 29, 2686\u20132687 (2023).","journal-title":"Nat. Med."},{"key":"1408_CR20","doi-asserted-by":"publisher","first-page":"eaao5333","DOI":"10.1126\/scitranslmed.aao5333","volume":"10","author":"WN Price","year":"2018","unstructured":"Price, W. N. Big Data and Black-Box Medical algorithms. Sci. Transl. Med. 10, eaao5333 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1408_CR21","doi-asserted-by":"crossref","unstructured":"Zwack, C. et al. The evolution of digital health technologies in cardiovascular disease research. npj Digit. Med. 6, 1 (2023).","DOI":"10.1038\/s41746-022-00734-2"},{"key":"1408_CR22","doi-asserted-by":"publisher","first-page":"e12432","DOI":"10.1111\/lnc3.12432","volume":"15","author":"D Hovy","year":"2021","unstructured":"Hovy, D. & Prabhumoye, S. Five sources of bias in natural language processing. Lang. Linguist. Compass 15, e12432 (2021).","journal-title":"Lang. Linguist. Compass"},{"key":"1408_CR23","doi-asserted-by":"publisher","unstructured":"Chowdhury, S. et al. Matching patients to clinical trials using LLaMA 2 embeddings and Siamese neural network. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.06.28.24309677 (2024).","DOI":"10.1101\/2024.06.28.24309677"},{"key":"1408_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMsr2214184","volume":"388","author":"P Lee","year":"2023","unstructured":"Lee, P., Bubeck, S. & Petro, J. Benefits, limits, and risks of GPT-4 as an AI Chatbot for medicine. N. Engl. J. Med. 388, 1233\u20131239 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1408_CR25","doi-asserted-by":"publisher","first-page":"e473590","DOI":"10.1200\/EDBK-25-473590","volume":"45","author":"T Azenkot","year":"2025","unstructured":"Azenkot, T., Rivera, D. R., Stewart, M. D. & Patel, S. P. Artificial intelligence and machine learning innovations to improve design and representativeness in oncology clinical trials. Am. Soc. Clin. Oncol. Educ. Book 45, e473590 (2025).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"1408_CR26","doi-asserted-by":"crossref","unstructured":"El Arab, R. et al. Bridging the gap: from AI success in clinical trials to real-world healthcare implementation\u2014a narrative review. Healthcare 13, 701 (2025).","DOI":"10.3390\/healthcare13070701"},{"key":"1408_CR27","doi-asserted-by":"publisher","unstructured":"Verlingue, L. et al. Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice. Lancet Reg. Health Eur. 46, https:\/\/doi.org\/10.1016\/j.lanepe.2024.101064 (2024).","DOI":"10.1016\/j.lanepe.2024.101064"},{"key":"1408_CR28","unstructured":"CommonSpirit Health. Health providers unite to advance patient care by forming Truveta. https:\/\/www.commonspirit.org\/news-articles\/health-providers-unite-to-advance-patient-care-by-forming-truveta (2020)."},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamainternmed.2019.0462","volume":"179","author":"B Gyawali","year":"2019","unstructured":"Gyawali, B., Hey, S. P. & Kesselheim, A. S. Assessment of the clinical benefit of cancer drugs receiving accelerated approval. JAMA Intern. Med. 179, 906 (2019).","journal-title":"JAMA Intern. Med."},{"key":"1408_CR30","doi-asserted-by":"crossref","unstructured":"Skrede, O. J. et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet 395, 350\u2013360 (2020).","DOI":"10.1016\/S0140-6736(19)32998-8"},{"key":"1408_CR31","doi-asserted-by":"crossref","unstructured":"Hartman, E. et al. Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis. Nat. Commun. 14, 5359 (2023).","DOI":"10.1038\/s41467-023-41146-4"},{"key":"1408_CR32","doi-asserted-by":"crossref","unstructured":"Pan, W. et al. Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning. Nat. Commun. 16, 3797 (2025).","DOI":"10.1038\/s41467-025-59092-8"},{"key":"1408_CR33","doi-asserted-by":"crossref","unstructured":"Yoo, S. K. et al. Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data. Nat. Med. 31, 869\u2013880 (2025).","DOI":"10.1038\/s41591-024-03398-5"},{"key":"1408_CR34","doi-asserted-by":"publisher","unstructured":"Venkat, A., Youlten, S. E., San Juan, B. P. et al. AAnet resolves a continuum of spatially-localized cell states to unveil intratumoral heterogeneity. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0684 (2025).","DOI":"10.1158\/2159-8290.CD-24-0684"},{"key":"1408_CR35","doi-asserted-by":"publisher","first-page":"1631898","DOI":"10.3389\/fmed.2025.1631898","volume":"12","author":"B Zhou","year":"2025","unstructured":"Zhou, B., Sun, S., Liu, S., Long, H. & Li, Y. A drug response prediction method for single-cell tumors combining attention networks and transfer learning. Front. Med. 12, 1631898 (2025).","journal-title":"Front. Med."},{"key":"1408_CR36","doi-asserted-by":"crossref","unstructured":"Sinha, S. et al. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nat. Cancer 5, 938\u2013952 (2024).","DOI":"10.1038\/s43018-024-00756-7"},{"key":"1408_CR37","doi-asserted-by":"crossref","unstructured":"Echle, A. et al. Artificial intelligence for detection of microsatellite instability in colorectal cancer\u2014a multicentric analysis of a pre-screening tool for clinical application. ESMO Open 7, 100400 (2022).","DOI":"10.1016\/j.esmoop.2022.100400"},{"key":"1408_CR38","doi-asserted-by":"crossref","unstructured":"Hu, Q. et al. Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images. npj Precis. Oncol. 8, 88 (2024).","DOI":"10.1038\/s41698-024-00560-7"},{"key":"1408_CR39","doi-asserted-by":"crossref","unstructured":"Jasti, J. et al. Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial. Nat. Commun. 16, 2610 (2025).","DOI":"10.1038\/s41467-025-57717-6"},{"key":"1408_CR40","doi-asserted-by":"publisher","unstructured":"Lotan, Y., Krishna, V. & Abuzeid, W. M. et al. Predicting response to intravesical BCG in high-risk NMIBC using an artificial intelligence\u2013powered pathology assay: development and validation in an International 12-Center Cohort. J. Urol. https:\/\/doi.org\/10.1097\/JU.0000000000004278 (2024).","DOI":"10.1097\/JU.0000000000004278"},{"key":"1408_CR41","doi-asserted-by":"crossref","unstructured":"Bai, Z. et al. Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning. npj Digit. Med. 8, 174 (2025).","DOI":"10.1038\/s41746-025-01560-y"},{"key":"1408_CR42","doi-asserted-by":"crossref","unstructured":"Qureshi, R. et al. Machine learning based personalized drug response prediction for lung cancer patients. Sci. Rep. 12, 18935 (2022).","DOI":"10.1038\/s41598-022-23649-0"},{"key":"1408_CR43","doi-asserted-by":"crossref","unstructured":"Blasiak, A. et al. Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial. npj Precis. Oncol. 9, 49 (2025).","DOI":"10.1038\/s41698-025-00835-7"},{"key":"1408_CR44","doi-asserted-by":"crossref","unstructured":"Pantuck, A. J. et al. Modulating BET bromodomain inhibitor ZEN-3694 and enzalutamide combination dosing in a metastatic prostate cancer patient using CURATE.AI, an artificial intelligence platform. Adv. Ther. 1, 1800104 (2018).","DOI":"10.1002\/adtp.201800104"},{"key":"1408_CR45","doi-asserted-by":"publisher","unstructured":"Turner, J. H. Avatar: personalized precision radio-genomic theranostic oncology. Cancer Biother. Radiopharm. https:\/\/doi.org\/10.1089\/cbr.2025.0152 (2025).","DOI":"10.1089\/cbr.2025.0152"},{"key":"1408_CR46","doi-asserted-by":"crossref","unstructured":"Niraula, D. et al. A decision support software for AI-assisted decision making in response-adaptive radiotherapy\u2014an evaluation study. Int. J. Radiat. Oncol. Biol. Phys. 114, e101\u2013e102 (2022).","DOI":"10.1016\/j.ijrobp.2022.07.895"},{"key":"1408_CR47","doi-asserted-by":"crossref","unstructured":"Niraula, D. et al. Intricacies of human\u2013AI interaction in dynamic decision-making for precision oncology. Nat. Commun. 16, 1138 (2025).","DOI":"10.1038\/s41467-024-55259-x"},{"key":"1408_CR48","doi-asserted-by":"publisher","first-page":"e1010200","DOI":"10.1371\/journal.pcbi.1010200","volume":"19","author":"D Baptista","year":"2023","unstructured":"Baptista, D., Ferreira, P. G. & Rocha, M. A systematic evaluation of deep learning methods for the prediction of drug synergy in cancer. PLoS Comput. Biol. 19, e1010200 (2023).","journal-title":"PLoS Comput. Biol."},{"key":"1408_CR49","doi-asserted-by":"crossref","unstructured":"Kuenzi, B. et al. Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell 38, 672\u2013684.e6 (2020).","DOI":"10.1016\/j.ccell.2020.09.014"},{"key":"1408_CR50","doi-asserted-by":"publisher","first-page":"108175","DOI":"10.1016\/j.compbiolchem.2024.108175","volume":"112","author":"KR Saranya","year":"2024","unstructured":"Saranya, K. R. & Vimina, E. R. DRN-CDR: A cancer drug response prediction model using multi-omics and drug features. Comput. Biol. Chem. 112, 108175 (2024).","journal-title":"Comput. Biol. Chem."},{"key":"1408_CR51","doi-asserted-by":"publisher","unstructured":"Lu, Z. et al. Small Language Models: Survey, Measurements, and Insights https:\/\/doi.org\/10.48550\/arXiv.2409.15790 (2025).","DOI":"10.48550\/arXiv.2409.15790"},{"key":"1408_CR52","doi-asserted-by":"publisher","first-page":"104009","DOI":"10.1016\/j.drudis.2024.104009","volume":"29","author":"M KP Jayatunga","year":"2024","unstructured":"KP Jayatunga, M., Ayers, M., Bruens, L., Jayanth, D. & Meier, C. How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons. Drug Discov. Today 29, 104009 (2024).","journal-title":"Drug Discov. Today"},{"key":"1408_CR53","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jmgm.2009.10.001","volume":"28","author":"B Chen","year":"2010","unstructured":"Chen, B. & Wild, D. J. PubChem BioAssays as a data source for predictive models. J. Mol. Graph. Model. 28, 420\u2013426 (2010).","journal-title":"J. Mol. Graph. Model."},{"key":"1408_CR54","doi-asserted-by":"crossref","unstructured":"Raies, A. et al. DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Commun. Biol. 5, 1291 (2022).","DOI":"10.1038\/s42003-022-04245-4"},{"key":"1408_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13321-023-00735-7","volume":"15","author":"M Cunningham","year":"2023","unstructured":"Cunningham, M. et al. PINNED: identifying characteristics of druggable human proteins using an interpretable neural network. J. Cheminform. 15, 64 (2023).","journal-title":"J. Cheminform."},{"key":"1408_CR56","doi-asserted-by":"publisher","unstructured":"Krishnan, S. R., Roy, A., Wong, L. & Gromiha, M. M. DRLiPS: a novel method for prediction of druggable RNA-small molecule binding pockets using machine learning. Nucleic Acids Res. 53, https:\/\/doi.org\/10.1093\/nar\/gkaf239 (2025).","DOI":"10.1093\/nar\/gkaf239"},{"key":"1408_CR57","doi-asserted-by":"publisher","unstructured":"Borhani, N., Izadi, I., Motahharynia, A., Sheikholeslami, M. & Gheisari, Y. DrugTar improves druggability prediction by integrating large language models and gene ontologies. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btaf360 (2025).","DOI":"10.1093\/bioinformatics\/btaf360"},{"key":"1408_CR58","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.isci.2022.104883","volume":"25","author":"P Charoenkwan","year":"2022","unstructured":"Charoenkwan, P. et al. Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework. iScience 25, 104883 (2022).","journal-title":"iScience"},{"key":"1408_CR59","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. KG4SL: knowledge graph neural network for synthetic lethality prediction in human cancers. Bioinformatics 37, i418\u2013i425 (2021).","DOI":"10.1093\/bioinformatics\/btab271"},{"key":"1408_CR60","doi-asserted-by":"crossref","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","DOI":"10.1038\/s41586-021-03819-2"},{"key":"1408_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104563","volume":"31","author":"CT Lin","year":"2026","unstructured":"Lin, C. T., Shiau, Y. P. & Lin, C. C. Machine learning in targeted protein degradation drug design: a technical review of PROTACs and molecular glues. Drug Discov. Today 31, 104563 (2026).","journal-title":"Drug Discov. Today"},{"key":"1408_CR62","doi-asserted-by":"publisher","first-page":"103020","DOI":"10.1016\/j.sbi.2025.103020","volume":"92","author":"J Sim","year":"2025","unstructured":"Sim, J., Kim, D., Kim, B., Choi, J. & Lee, J. Recent advances in AI-driven protein-ligand interaction predictions. Curr. Opin. Struct. Biol. 92, 103020 (2025).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1408_CR63","doi-asserted-by":"publisher","unstructured":"Wu, K. et al. Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling. Front. Pharmacol. 15, https:\/\/doi.org\/10.3389\/fphar.2024.1330855 (2024).","DOI":"10.3389\/fphar.2024.1330855"},{"key":"1408_CR64","doi-asserted-by":"crossref","unstructured":"Lu, H. et al. Design, synthesis, and biological evaluation of novel orally available covalent CDK12\/13 dual inhibitors for the treatment of tumors. J. Med. Chem. 68, 4148\u20134167 (2025).","DOI":"10.1021\/acs.jmedchem.4c01616"},{"key":"1408_CR65","doi-asserted-by":"crossref","unstructured":"Zhang, D. et al. Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy. EBioMedicine 105, 105212 (2024).","DOI":"10.1016\/j.ebiom.2024.105212"},{"key":"1408_CR66","doi-asserted-by":"crossref","unstructured":"Cui, C. et al. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug\u2013drug links based on graph neural network. Bioinformatics 37, 2930\u20132937 (2021).","DOI":"10.1093\/bioinformatics\/btab191"},{"key":"1408_CR67","doi-asserted-by":"publisher","first-page":"101419","DOI":"10.1016\/j.genrep.2021.101419","volume":"25","author":"E Nazari","year":"2021","unstructured":"Nazari, E., Aghemiri, M., Avan, A., Mehrabian, A. & Tabesh, H. Machine learning approaches for classification of colorectal cancer with and without feature selection method on microarray data. Gene Rep. 25, 101419 (2021).","journal-title":"Gene Rep."},{"key":"1408_CR68","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.trecan.2024.12.001","volume":"11","author":"M Ligero","year":"2025","unstructured":"Ligero, M., Nahhas, O. S. M., El, Aldea, M. & Kather, J. N. Artificial intelligence-based biomarkers for treatment decisions in oncology. Trends Cancer 11, 232\u2013244 (2025).","journal-title":"Trends Cancer"},{"key":"1408_CR69","doi-asserted-by":"publisher","first-page":"102658","DOI":"10.1016\/j.sbi.2023.102658","volume":"82","author":"M Stanley","year":"2023","unstructured":"Stanley, M. & Segler, M. Fake it until you make it? Generative de novo design and virtual screening of synthesizable molecules. Curr. Opin. Struct. Biol. 82, 102658 (2023).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1408_CR70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13321-025-01108-y","volume":"17","author":"R \u00d6z\u00e7elik","year":"2025","unstructured":"\u00d6z\u00e7elik, R. & Grisoni, F. How evaluation choices distort the outcome of generative drug discovery. J. Cheminform. 17, 169 (2025).","journal-title":"J. Cheminform."},{"key":"1408_CR71","doi-asserted-by":"publisher","first-page":"e232300","DOI":"10.1001\/jamahealthforum.2023.2300","volume":"4","author":"S Gottlieb","year":"2023","unstructured":"Gottlieb, S. & Silvis, L. Regulators face novel challenges as artificial intelligence tools enter medical practice. JAMA Health Forum 4, e232300 (2023).","journal-title":"JAMA Health Forum"},{"key":"1408_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-02072-6","volume":"18","author":"H Han","year":"2025","unstructured":"Han, H. Challenges of reproducible AI in biomedical data science. BMC Med Genom. 18, 8 (2025).","journal-title":"BMC Med Genom."},{"key":"1408_CR73","doi-asserted-by":"crossref","unstructured":"Derraz, B. et al. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. npj Precis. Oncol. 8, 23 (2024).","DOI":"10.1038\/s41698-024-00517-w"},{"key":"1408_CR74","doi-asserted-by":"crossref","unstructured":"Westphalen, C. B. et al. ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice. Ann. Oncol. 36, 614\u2013625 (2025).","DOI":"10.1016\/j.annonc.2025.02.009"},{"key":"1408_CR75","unstructured":"Advancing Precision Medicine for Europe\u2019s Cancer Patients with AI-Powered Imaging Joint Statement https:\/\/eosc4cancer.eu\/."},{"key":"1408_CR76","doi-asserted-by":"publisher","unstructured":"Sebastian, A. M. & Peter, D. Artificial intelligence in cancer research: trends, challenges and future directions. 12, 1991 https:\/\/doi.org\/10.3390\/life12121991 (2022).","DOI":"10.3390\/life12121991"},{"key":"1408_CR77","doi-asserted-by":"publisher","first-page":"217821","DOI":"10.1016\/j.canlet.2025.217821","volume":"627","author":"S Sarvepalli","year":"2025","unstructured":"Sarvepalli, S. & Vadarevu, S. Role of artificial intelligence in cancer drug discovery and development. Cancer Lett. 627, 217821 (2025).","journal-title":"Cancer Lett."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01408-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:50:34Z","timestamp":1781477434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01408-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01408-y","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}